Why is PRLD stock up today?

Prelude Therapeutics Incorporated (PRLD) is up 0.0% today. A recent SEC filing (Clinical / FDA update) may be a factor. Volume is running about 0.0x its recent daily average.

Why is $PRLD stock moving today?

Prelude Therapeutics Incorporated · Pharmaceutical Preparations

Why is $PRLD moving today?

The likely driver

Clinical / FDA update

Prelude Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for PRT13722, Its First-in-Class Oral KAT6A Selective Degrader

SEC filing · Sep 10

The numbers behind the move

Short interest

52% of float

Days to cover

11.5d

Float

9.8M · High

Dilution

Heavy

Insider buying

5 open-market

PRLD: 52% of the float is sold short (11.5 days to cover), active share dilution on file, 5 open-market insider buys.

Price

$4.15

Move today

+0.0%

Volume vs avg

0.0x

Scanner alerts today

Flagged in 30 days

Market cap

$310M

Prev close

$4.15

Avg volume

499K

Nothing has triggered on PRLD yet in this session. Our scanner has flagged it 38 times in the last 30 days , most recently on October 27 for big percentage moves, unusual volume, which is why this page is here. See the full PRLD page for the chart and the alert history.

Full $PRLD page →Live chart Trending stocks

Free alerts

Get free $PRLD alerts the moment volume spikes

Our scanner flagged $PRLD 38 times in the last 30 days. Create a free account to track $PRLD, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts

No card · 5 premium days · join 800+ traders

Other stocks moving today

$ETSY +8.9%$YMAT +8.5%$SKHY +7.9%$NXPI -7.9%$HOOD -7.7%$SEDG -7.6%$FFIV -7.5%$ICLR +7.1%

Each opens that stock’s own why-is-it-moving page.

Move and volume are based on the latest market data and refresh live on this page. Scanner alerts are our own real-time unusual-volume signals. This is research, not investment advice.